GYRE | tickerfilter.com

Fundamental analysis

49%

Profitability 32%

Dept financing 32%

Liquidity 75%

Performance 64%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

4.62%

1 Month

-29.91%

3 Months

-27.53%

6 Months

-42.68%

1 Year

-57.41%

2 Year

135.10%

Key data

Stock price

$7.24

P/E Ratio

93.64

DAY RANGE

$7.06 - $8.85

EPS

$0.14

52 WEEK RANGE

$6.17 - $19.00

52 WEEK CHANGE

-$47.84

MARKET CAP

1.132 B

YIELD

N/A

SHARES OUTSTANDING

93.424 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-15-2025

BETA

1.49

PUBLIC FLOAT

AVERAGE 10 VOLUME

$275,402

AVERAGE 30 VOLUME

$254,993

Company detail

CEO: Han Ying
Region: US
Website: www.gyretx.com
Employees: 40
IPO year: 2015

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Gyre Therapeutics is a biopharmaceutical company headquartered in San Diego, CA.

GYRE - GYRE THERAPEUTICS, INC.